Immunome, Inc. · NASDAQ:IMNM
Redmile Group, LLC's stake in Immunome, Inc. fell to 6.20% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Redmile Group, LLC's stake in Immunome, Inc. fell to 6.20%, 5,361,187 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 5,361,187
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 6.20% | 5,361,187 |
| Jeremy C. Green | 6.20% | 5,361,187 |
| Redmile Biopharma Investments III, L.P. | 4.50% | 3,879,415 |
Source
Related
- Immunome, Inc.
- Redmile Group, LLC
- Immunome, Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · May 15, 2026
- Schedule 13G/A · Redmile Group, LLC · Feb 17, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026